Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 89979132 | 8997913 | 2 | F | 20160824 | 20130104 | 20160826 | EXP | US-JNJFOC-20121213120 | JANSSEN | NICOL GE, EDLER J, KYMES SM, NEWCOMER JW. ECONOMIC EVALUATION OF ANTIPSYCHOTIC TREATMENT IN PEDIATRIC DISRUPTIVE BEHAVIOR DISORDERS: AN EXAMPLE FROM THE METABOLIC EFFECTS OF ANTIPSYCHOTICS IN CHILDREN (MEAC) STUDY. AMERICAN COLLEGE OF NEUROPSYCHOPHARMACOLOGY 2012;38 (SUPPL. 1):S410 - S411 (W163). NEWCOMER JW. RESULTS FROM THE NIMH-FUNDED METABOLIC EFFECTS OF ANTIPSYCHOTICS IN CHILDREN (MEAC) STUDY. SCHIZOPHRENIA RESEARCH 2014;153:S19. | 0.00 | Y | 0.00000 | 20160826 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 89979132 | 8997913 | 1 | PS | RISPERIDONE. | RISPERIDONE | 1 | Unknown | U | U | 20272 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 89979132 | 8997913 | 1 | Disturbance in social behaviour |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 89979132 | 8997913 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 89979132 | 8997913 | Obesity | |
| 89979132 | 8997913 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |